We use 1H NMR metabolomics to measure the impact of immunotherapy intended to target glioblastoma multiforme in a murine model. Cellular immunotherapy is a promising new platform for cancer treatment. Analysis of the urine of C57Bl6 mice revealed a set of metabolites associated with changes in glycolysis after immunotherapy treatment.
This abstract and the presentation materials are available to members only; a login is required.